Clinical Trial Update: The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and efficacy of sublingual and oral immunotherapy for milk protein allergy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Milk Allergy

Drugs mentioned

• Milk protein immunotherapy (sublingual and oral) (milk protein immunotherapy (sublingual and oral))

Snippet

Sponsor: Johns Hopkins University | Conditions: Milk Allergy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-15